前列腺特异性抗原（PSA）筛查与前列腺癌风险降低 - Suppr

PSA screening and prostate cancer risk reduction.

作者信息

Andriole Gerry L

机构信息

Division of Urologic Surgery, Washington University in St Louis, St Louis, MO 63110, USA.

出版信息

Urol Oncol. 2012 Nov-Dec;30(6):936-7. doi: 10.1016/j.urolonc.2012.09.009.

DOI:10.1016/j.urolonc.2012.09.009

PMID:23218069

Abstract

摘要

相似文献

PSA screening and prostate cancer risk reduction.

Urol Oncol. 2012 Nov-Dec;30(6):936-7. doi: 10.1016/j.urolonc.2012.09.009.

Screening by the prostate-specific antigen test: what do the patients know?

J Cancer Educ. 1996 Spring;11(1):39-44. doi: 10.1080/08858199609528390.

[Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].

Hinyokika Kiyo. 1993 Mar;39(3):221-3.

[Prostatic specific antigen in practice in 1997].

Ann Urol (Paris). 1998;32(2):69-72.

Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.

Eur Urol. 2009 May;55(5):e88-9; author reply e90-1. doi: 10.1016/j.eururo.2008.11.036. Epub 2008 Nov 29.

The case for prostate cancer screening.

Semin Urol. 1993 May;11(2):50-3.

Screening for prostate cancer in 2006: PSA in the 21st century.

N C Med J. 2006 Mar-Apr;67(2):136-9.

Screening for prostate cancer utilizing the prostate-specific antigen (PSA).

N C Med J. 1993 Sep;54(9):443-6.

Screening for prostate cancer: the role of prostate-specific antigen.

Md Med J. 1996 Nov;45(11):938-40.

PSA screening: the bottom line.

CMAJ. 2000 Mar 21;162(6):791-2.

引用本文的文献

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.

Cancers (Basel). 2019 Jun 10;11(6):802. doi: 10.3390/cancers11060802.

Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis.

Sci Rep. 2018 May 10;8(1):7459. doi: 10.1038/s41598-018-25798-7.

Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol.

JMIR Res Protoc. 2016 Jun 13;5(2):e98. doi: 10.2196/resprot.5433.

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.

Oncologist. 2016 Jun;21(6):716-22. doi: 10.1634/theoncologist.2015-0336. Epub 2016 May 5.

Novel tools for prostate cancer prognosis, diagnosis, and follow-up.

Biomed Res Int. 2014;2014:890697. doi: 10.1155/2014/890697. Epub 2014 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

PSA screening and prostate cancer risk reduction.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献